Study Findings on Glioblastomas Described by a Researcher at University of Ilorin (Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence).

Předmět:
Zdroj: Drug Week; 12/22/2023, p1934-1934, 1p
Abstrakt: A recent study conducted by researchers at the University of Ilorin in Nigeria explores the efficacy of Tumour-Treating Fields (TTFields) Therapy in the treatment of recurrent Glioblastoma, a type of aggressive brain cancer. The study reviews various academic databases to identify relevant studies published within the last decade and highlights the potential clinical benefits of TTFields Therapy. The therapy has shown positive impacts on overall survival and progression-free survival, with mild to moderate skin reactions being the most commonly reported adverse events. The research suggests that TTFields Therapy could be a valuable addition to the treatment options for recurrent Glioblastoma. [Extracted from the article]
Databáze: Complementary Index